Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20017104HPVENSG00000134853.12protein_codingPDGFRAYesNo5156P16234
TVIS20058559HPVENSG00000134853.12protein_codingPDGFRAYesNo5156P16234
TVIS44048880HTLV-1ENSG00000134853.12protein_codingPDGFRAYesNo5156P16234
TCGA Plot Options
Drug Information
GenePDGFRA
DrugBank IDDB00619
Drug NameImatinib
Target IDBE0000852
UniProt IDP16234
Regulation Typeantagonist
PubMed IDs15894928; 15921304; 15928335; 15946589; 15995325
CitationsYi ES, Strong CR, Piao Z, Perucho M, Weidner N: Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity. Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):157-61.@@Borbenyi Z: [Disorders with eosinophilia, treatment of hypereosinophilic syndrome]. Orv Hetil. 2005 May 1;146(18 Suppl 1):911-6.@@Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, Shiraga S, Bainbridge T, Morich J, Heinrich MC: PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol. 2005 Aug 10;23(23):5357-64. Epub 2005 May 31.@@Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS: Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep. 2005 Jul;7(4):293-9.@@Tefferi A: Modern diagnosis and treatment of primary eosinophilia. Acta Haematol. 2005;114(1):52-60.
GroupsApproved
Direct ClassificationBenzanilides
SMILESCN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
PathwaysImatinib Inhibition of BCR-ABL
PharmGKBPA10804
ChEMBLCHEMBL941